About William Niland
Form D filings for Secretome Therapeutics in 2023 list William Niland as director.
William Niland first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name William Niland in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Niland works with at each company, as listed on that company's latest Form D.
Secretome Therapeutics, Inc. · Form D, Feb 2, 2023
AS
Angela Shen
Director
HR
Henrik Rasmussen
Director
VJ
Vineet Jindal
Chief Executive Officer and director
SK
Sunjay Kaushal
Director